Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Wirksamkeit von Alemtuzumab und Gemcitabine in einer Patientin mit enteropathischem T-Zell Lymphom
Siano M. Wirksamkeit von Alemtuzumab und Gemcitabine in einer Patientin mit enteropathischem T-Zell Lymphom - Der seltene Fall. Schweizer Krebsbulletin 2007; 27
01.04.2007Wirksamkeit von Alemtuzumab und Gemcitabine in einer Patientin mit enteropathischem T-Zell Lymphom
01.04.2007Schweizer Krebsbulletin 2007; 27
Siano Marco
Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study
Langer I, Zuber M, Burger D, Infanger E, Uehlinger U, Wight E, Schnarwyler B, Bronz L, Oertli D, Hess T, Fehr M, Schaer G, Singer G, Berclaz G, Koechli O, Gueller U, Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study. Ann Surg Oncol 2007; 14:1896-903.
14.03.2007Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study
14.03.2007Ann Surg Oncol 2007; 14:1896-903
Langer Igor, Zuber Markus, Burger Daniel, Infanger Eduard, Uehlinger Urs, Wight Edward, Schnarwyler Beate, Bronz Lucio, Oertli Daniel, Hess Thomas, Fehr Mathias K, Schaer Gabriel, Singer Gad, Berclaz Gilles, Koechli Ossi R, Gueller Ulrich, Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer
Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma
Koch D, Hundsberger T, Boor S, Kaina B. Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma. Journal of neuro-oncology 2007; 82:85-9.
01.03.2007Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma
01.03.2007Journal of neuro-oncology 2007; 82:85-9
Koch Dorothee, Hundsberger Thomas, Boor Stephan, Kaina Bernd
Impact of surgeon and hospital caseload on the likelihood of performing laparoscopic vs open sigmoid resection for diverticular disease: a study based on 55,949 patients
Weber W, Gueller U, Jain N, Pietrobon R, Oertli D. Impact of surgeon and hospital caseload on the likelihood of performing laparoscopic vs open sigmoid resection for diverticular disease: a study based on 55,949 patients. Arch Surg 2007; 142:253-9; discussion 259.
01.03.2007Impact of surgeon and hospital caseload on the likelihood of performing laparoscopic vs open sigmoid resection for diverticular disease: a study based on 55,949 patients
01.03.2007Arch Surg 2007; 142:253-9; discussion 259
Weber Walter P, Gueller Ulrich, Jain Nitin B, Pietrobon Ricardo, Oertli Daniel
Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
Langer I, Burger D, Infanger E, Uehlinger U, Wight E, Schnarwyler B, Bronz L, Oertli D, Hess T, Fehr M, Schaer G, Koechli O, Berclaz G, Gueller U, Zuber M. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245:452-61.
01.03.2007Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
01.03.2007Ann Surg 2007; 245:452-61
Langer Igor, Burger Daniel, Infanger Eduard, Uehlinger Urs, Wight Edward, Schnarwyler Beate, Bronz Lucio, Oertli Daniel, Hess Thomas, Fehr Mathias K, Schaer Gabriel, Koechli Ossi R, Berclaz Gilles, Gueller Ulrich, Zuber Markus
Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
Strasser F, Binswanger J, Cerny T, Kesselring A. Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study. Palliative medicine 2007; 21:129-37.
01.03.2007Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study
01.03.2007Palliative medicine 2007; 21:129-37
Strasser F, Binswanger J, Cerny Thomas, Kesselring A
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
Sessa C, Marsoni S, Zanna C, Carminati P, Gatti B, Capri G, Zaniboni A, D'Incalci M, Zucchetti M, Trigo J, Hess D, Malossi A, Rota Caremoli E, Baselga J, Cerny T, Cresta S, Gianni L. Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007; 18:561-8.
01.03.2007Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
01.03.2007Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007; 18:561-8
Sessa C, Marsoni S, Zanna C, Carminati P, Gatti B, Capri G, Zaniboni A, D'Incalci M, Zucchetti M, Trigo J, Hess D, Malossi A, Rota Caremoli E, Baselga J, Cerny Thomas, Cresta S, Gianni L
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
Hau P, Koch H, Jauch T, Schuth J, Rieckmann P, Brenner A, Rauch M, Rudolph R, Bauer B, Marg E, Hundsberger T, Koch D, Bogdahn U. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 2007; 68:688-90.
27.02.2007Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma
27.02.2007Neurology 2007; 68:688-90
Hau P, Koch H, Jauch T, Schuth J, Rieckmann P, Brenner A, Rauch M, Rudolph R, Bauer B, Marg E, Hundsberger Thomas, Koch D, Bogdahn U
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
Coates A, Del Mastro L, Smith I, Chirgwin J, Nogaret J, Pienkowski T, Wardley A, Jakobsen E, Price K, Láng I, Colleoni M, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes J, Paridaens R, Castiglione-Gertsch M, Gelber R, Goldhirsch A. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. JCO 2007; 25:486-92.
10.02.2007Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
10.02.2007JCO 2007; 25:486-92
Coates Alan S, Del Mastro Lucia, Smith Ian, Chirgwin Jacquie, Nogaret Jean-Marie, Pienkowski Tadeusz, Wardley Andrew, Jakobsen Erik H, Price Karen N, Láng István, Colleoni Marco, Keshaviah Aparna, Thürlimann Beat, Mouridsen Henning, Mauriac Louis, Forbes John F, Paridaens Robert, Castiglione-Gertsch Monica, Gelber Richard D, Goldhirsch Aron
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII
Bernhard J, Coates A, Goldhirsch A, Price K, Thürlimann B, Aebi S, Collins J, Murray E, Forbes J, Gelber R, Hürny C, Castiglione-Gertsch M, Zahrieh D, International Breast Cancer Study Group Trial VIII. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. JCO 2007; 25:263-70.
20.01.2007Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII
20.01.2007JCO 2007; 25:263-70
Bernhard Jürg, Coates Alan S, Goldhirsch Aron, Price Karen N, Thürlimann Beat, Aebi Stefan, Collins John, Murray Elizabeth, Forbes John F, Gelber Richard D, Hürny Christoph, Castiglione-Gertsch Monica, Zahrieh David, International Breast Cancer Study Group Trial VIII
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
Kraus M, Ovaa H, Overkleeft H, Burg D, Berkers C, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen C. Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92.
01.01.2007Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
01.01.2007Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92
Kraus Marianne, Ovaa H, Overkleeft H, Burg D, Berkers C R, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen Christoph
Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
Inauen R, Cathomas R, Boehm T, Pestalozzi B, Gillessen Sommer S, von Moos R. Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure. Oncology 2007; 72:209-10.
01.01.2007Feasibility of using cetuximab and bevacizumab in a patient with colorectal cancer and terminal renal failure
01.01.2007Oncology 2007; 72:209-10
Inauen Roman, Cathomas R, Boehm T, Pestalozzi B C, Gillessen Sommer Silke, von Moos R
Sinnvoll?
Templeton A, Gillessen Sommer S. Sinnvoll?. Schweiz Med Forum 2007; 7:469.
01.01.2007Sinnvoll?
01.01.2007Schweiz Med Forum 2007; 7:469
Templeton Arnoud, Gillessen Sommer Silke
Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis
Rohr L, Klaeser B, Jörger M, Kluckert J, Cerny T, Gillessen Sommer S. Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis. Onkologie 2007:320-323.
01.01.2007Increased pulmonary FDG Uptake in Bleomycin-associated pneumonitis
01.01.2007Onkologie 2007:320-323
Rohr L., Klaeser B, Jörger Markus, Kluckert Jörg-Thomas, Cerny Thomas, Gillessen Sommer Silke
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)
Hess D, Ribi K, Ballabeni P, Schuller J, Rauch D, Rochlitz C, Mattmann S, Schonenberger A, Pagani O, Thürlimann B, Köberle D, Swiss Group for Clinical Cancer Research. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Oncology 2007; 73:228-37.
01.01.2007Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)
01.01.2007Oncology 2007; 73:228-37
Hess Dagmar, Ribi K, Ballabeni P, Schuller J C, Rauch D, Rochlitz C, Mattmann S, Schonenberger A, Pagani O, Thürlimann Beat, Köberle Dieter, Swiss Group for Clinical Cancer Research
An update on the pharmacological management of the cancer anorexia-cachexia-syndrome
Templeton A, Omlin A, Strasser F. An update on the pharmacological management of the cancer anorexia-cachexia-syndrome. European Journal of Palliative Care 2007; 14:186-190.
01.01.2007An update on the pharmacological management of the cancer anorexia-cachexia-syndrome
01.01.2007European Journal of Palliative Care 2007; 14:186-190
Templeton Arnoud, Omlin Aurelius, Strasser Florian
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG
Jörger M, Féty R, de Bruijn E, Hempel G, Karlsson M, Tranchand B, Schrijvers A, Twelves C, Beijnen J, Schellens J, Jodrell D, Izquierdo M, Sleeboom H, Huitema A, Richel D, Dittrich C, Pavlidis N, Briasoulis E, Vermorken J, Strocchi E, Martoni A, Sorio R, EORTC-PAMM-NDDG. Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG. Clinical pharmacokinetics 2007; 46:1051-68.
01.01.2007Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG
01.01.2007Clinical pharmacokinetics 2007; 46:1051-68
Jörger Markus, Féty Régine, de Bruijn Ernst, Hempel Georg, Karlsson Mats, Tranchand Brigitte, Schrijvers Ad H G J, Twelves Chris, Beijnen Jos H, Schellens Jan H M, Jodrell Duncan I, Izquierdo Miguel A, Sleeboom Henk P, Huitema Alwin D R, Richel Dick J, Dittrich Christian, Pavlidis Nikolas, Briasoulis Evangelos, Vermorken Jan B, Strocchi Elena, Martoni Andrea, Sorio Roberto, EORTC-PAMM-NDDG
Adjuvante Therapie des Kolonkarzinoms
Greuter S, Jörger M, Köberle D. Adjuvante Therapie des Kolonkarzinoms. Onkologie 2007; 3:20-24.
01.01.2007Adjuvante Therapie des Kolonkarzinoms
01.01.2007Onkologie 2007; 3:20-24
Greuter S, Jörger Markus, Köberle Dieter
Probleme langwirkender Betamimetika bei Asthma
Jörger M, Kuhn M. Probleme langwirkender Betamimetika bei Asthma. Pharma-Kritik 2007; 29
01.01.2007Probleme langwirkender Betamimetika bei Asthma
01.01.2007Pharma-Kritik 2007; 29
Jörger Markus, Kuhn M
Erfahrungen an der Grenze des Erfahrbaren - Spiritualität und das Medium Musik
Renz M. Erfahrungen an der Grenze des Erfahrbaren - Spiritualität und das Medium Musik. Musiktherapeutische Umschau 2007; 28:205-216.
01.01.2007Erfahrungen an der Grenze des Erfahrbaren - Spiritualität und das Medium Musik
01.01.2007Musiktherapeutische Umschau 2007; 28:205-216
Renz Monika